# ClaimsFiler

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/claimsfiler
Canonical HTML page: https://getyourbrief.com/entity/claimsfiler

## Timeline

- **2026-Q3**: Anticipated Amended Complaint — Expected filing of detailed allegations following the appointment of lead plaintiffs.
- **2026-04-13**: Lead Plaintiff Deadline — Final date for eligible investors to file applications to lead the class action lawsuits.
- **2026-04-13**: Lead Plaintiff Deadline — Final date for eligible investors to file applications in the class action lawsuits against QURE and KD.
- **2026-Q2**: Judicial Review — Courts expected to begin selecting lead plaintiffs and lead counsel for the consolidated cases.
- **2026-02-18**: Shareholder Alerts Issued — ClaimsFiler releases formal reminders for KD and QURE investors regarding legal deadlines.
- **2026-02-18**: Legal Alert Issued — ClaimsFiler reminds shareholders of upcoming deadlines for lead plaintiff applications.

## Recent coverage (3 stories, network-wide)

### Legacy vs. Frontier: Analyzing Kyndryl and Soluna’s Divergent Data Strategies
2026-02-21 02:37:33 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Kyndryl and Soluna Holdings represent two polar extremes of the data infrastructure market, with the former struggling through a legacy pivot and the latter expanding its green-energy computing footprint. While Kyndryl faces legal and financial headwinds following a major earnings miss, Soluna is capitalizing on the high-performance computing boom through strategic Texas expansions.
Full story: https://getfinancebrief.com/story/kyndryl-soluna-data-infrastructure-comparison-2026

### uniQure and Kyndryl Face April Deadlines in Securities Class Action Lawsuits
2026-02-19 19:43:15 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Investors in uniQure N.V. and Kyndryl Holdings have until April 13, 2026, to file as lead plaintiffs in securities class action lawsuits following significant stock losses. The litigation highlights increasing regulatory and disclosure pressures on biotech firms specializing in complex gene therapies.
Full story: https://getbiobrief.com/story/uniqure-kyndryl-securities-class-action-deadlines

### Kyndryl and uniQure Face April Deadlines in Securities Class Action Lawsuits
2026-02-19 19:42:41 · Sector: legal · Sentiment: Neutral · Impact: 5/10 · Sources: 2

ClaimsFiler has issued a critical reminder for investors in Kyndryl Holdings and uniQure N.V. regarding upcoming lead plaintiff deadlines in ongoing securities class action litigation. Shareholders with losses exceeding $100,000 have until April 13, 2026, to seek lead plaintiff status in cases alleging potential violations of federal securities laws.
Full story: https://getlegalbrief.com/story/kyndryl-uniqure-securities-litigation-deadlines-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.